BioMEMS

BioMEMS

Microelectronics, Which Has Led To The Explosion Of Consumer Electronics Sales, Can Now Bring Its Added Value To Life Science Applications. The Key Challenge For Microelectronics Is To Make Complexity Invisible And Adapt It To The Value Chain And Way Of Working To The Life Science Industries

Microsystems technologies are changing the Life Sciences industry. New in-vitro diagnostic systems, new therapy strategies, genetic diseases treatment, targeted and intelligent drug delivery, artificial pancreas, drug discovery processes… are healthcare improvements promised to future generations, enabled by semiconductor and MEMS technologies. The Life Sciences industry already faces critical challenges in addressing this expected market.

To take part in this innovation process, it is very important to understand the technology and industrial trends by having a good knowledge of currently used technologies, their limits and advantages, their applications and the way the Life Sciences industry currently works. Indeed, Life Science is a broad field including industries like drug discovery, in-vitro diagnostics, medical devices, instrumentation… In the same way, the market is segmented by applications, technologies and specific medical use.

Yole’s BioMEMS 2008 report answers the question: How Microsystems and Semiconductor companies can become key suppliers to the Life Sciences field?

The report will enable you to:

• Understand the Life Science market and define your strategy to address it
  
  
• Understand the main regulatory requirements (FDA, EMEA, JMHLW…)
  
  
• Get an overview of the main techniques in use or under development and the trends for the coming years
  
  
• Understand the real added value of Microsystems and Semiconductors to the Life Science industry
  
  
• Understand the main MEMS and Semiconductors success stories in the Life Science market